Page last updated: 2024-12-06

3,5-dichlorocatechol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-Dichlorocatechol, also known as 3,5-dichloro-1,2-benzenediol, is a chlorinated catechol that exists as a white crystalline solid. It is an important industrial intermediate and is used in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. The compound is often synthesized through the chlorination of catechol. It is a potent inhibitor of the enzyme tyrosinase, which is involved in the production of melanin. This inhibition makes 3,5-dichlorocatechol a potential therapeutic agent for the treatment of hyperpigmentation disorders. The compound also exhibits antimicrobial activity against a range of bacteria and fungi. Due to its potential applications in medicine, agriculture, and industry, 3,5-dichlorocatechol has been the subject of extensive research. Studies have focused on its synthesis, biological activity, and environmental fate. The compound is known to be toxic to aquatic organisms and can persist in the environment. Its potential environmental impact is a key area of ongoing research.'

3,5-dichlorocatechol : A dichlorocatechol carrying chloro groups at positions 3 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID26173
CHEBI ID15788
SCHEMBL ID70194
MeSH IDM0176232

Synonyms (30)

Synonym
CHEBI:15788
1,2-dihydroxy-4,6-dichlorobenzene
3,5-dichlorobenzene-1,2-diol
3,5-dichlorocatechol
C02933
13673-92-2
3,5-dichlorocatechol, 97%
3,5-dichloropyrocatechol
3,5-dichloro-1,2-dihydroxybenzene
3,5-dichloro-1,2-benzenediol
1,2-benzenediol, 3,5-dichloro-
3,5-dichloro-benzene-1,2-diol
BMSE000336
AKOS003368034
35C ,
ccris 4063
SCHEMBL70194
3I4Y
XSXYVLIPQMXCBV-UHFFFAOYSA-N
3,5-dichloro-1,2-benzenediol #
DTXSID5074509
J-006900
3 5-dichlorocatechol 97
Q27098232
HY-133609
CS-0128393
SY299571
mfcd02683889
F87383
EN300-1599476
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dichlorocatecholA chlorocatechol carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
1,3-dichlorobenzene degradation57
3,5-dichlorocatechol degradation813
2,4-dichlorophenoxyacetate degradation314

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Catechol 1,2-dioxygenaseRhodococcus opacusKi0.09000.02000.05500.0900AID977610
Chain A, Catechol 1,2-dioxygenaseRhodococcus opacusKi0.09000.02000.05500.0900AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2010Journal of structural biology, Jun, Volume: 170, Issue:3
Catechol 1,2-dioxygenase from the Gram-positive Rhodococcus opacus 1CP: quantitative structure/activity relationship and the crystal structures of native enzyme and catechols adducts.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's6 (60.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.30 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]